Evidence map›Paper›PMID 40461853›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Recurrent angiofibroma: analysis of risk factors and common sites of recurrence.

Hisham Mohamed Anwar Attya, Mohamed Salah Hassouna, Abdelrahman Ali Shawky, Mena Esmat Abdelmalek

Abstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Benign Sinonasal Tumors: A 17-Year Single Center Experience.Turkish archives of otorhinolaryngology · 2026
    Article
  2. Article
  3. Letter to 'Recurrent angiofibroma: analysis of risk factors and common sites of recurrence'.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Hisham Mohamed Anwar AttyaCairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.ORCID http://orcid.org/0000-0002-7175-8666
Mohamed Salah HassounaCairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.
Abdelrahman Ali ShawkyCairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt. abdulrahman.shawki37266@postgrad.kasralainy.edu.eg.ORCID http://orcid.org/0009-0002-9497-7113
Mena Esmat AbdelmalekCairo University Kasr Alainy Faculty of Medicine, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo detect risk factors and common anatomical sites for recurrence of juvenile nasopharyngeal angiofibroma (JNA).

methodsThis is a retrospective study, included all male patients who were diagnosed histopathologically with juvenile nasopharyngeal angiofibroma (JNA) and were operated before at Kasr Al-Ainy Hospital, Cairo University in the period between January 2012 and December 2021. Their clinical data were retrieved and analyzed.

resultsAmong 68 patients included in this study, 26 patients experienced recurrence with total recurrence rate (38.2%). JNA recurrence was significantly associated with primary tumor size (≥ 4 cm), advanced primary tumor stages (stage IIIa, IIIb according to Radkowski classification) and their correlatives of preoperative embolization, perioperative blood transfusion or open surgical approach. Age on presentation, tumor stage, perioperative blood transfusion and tumor size were significant factors affecting the recurrence rate according to cox regression univariate analysis, while on multivariate analysis the only significant independent predictors of JNA recurrence were age on presentation and tumor size. 61.53% of recurrent cases were discovered accidently through their regular postoperative follow up examination and/or imaging and were asymptomatic upon diagnosis of recurrence. Moreover, patients with early tumor stage or didn't undergo preoperative embolization or had a primary tumor size < 4 cm had significantly longer recurrence interval than those with advanced tumor stage or underwent preoperative embolization or had a primary tumor size ≥ 4 cm. Pterygoid process (92.3%) was significantly the commonest to be invaded by recurrent/residual tumor, followed by nasopharynx (84.6%) and sphenoid sinus (76.9%).

conclusionJNA recurrence is significantly associated with primary tumor size, primary tumor stage and their correlatives of preoperative embolization, perioperative blood transfusion or open surgical approach, but age on presentation and primary tumor size were the only independent predictors of tumor recurrence. Meticulous surgical attention should be paid for pterygoid process in order to decrease residual/recurrence incidence.

Indexed as

AngiofibromaNasopharyngeal NeoplasmsNeoplasm Recurrence, LocalAdolescentAdultChildChild, PreschoolEmbolization, TherapeuticHumansMaleNeoplasm StagingRetrospective StudiesRisk FactorsYoung AdultJuvenile nasopharyngeal angiofibromaRecurrenceRisk factors

Identifiers

PMID40461853
PMCPMC12321937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.